BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4603402)

  • 1. [Clinical pharmacology and biological characteristics of 3-tetrahydropyranyl ether of 17-beta-estradiol].
    Locardi G
    Minerva Ginecol; 1972 Feb; 24(2):70-81. PubMed ID: 4603402
    [No Abstract]   [Full Text] [Related]  

  • 2. [On some pharmacobiological characteristics of a new estrogen derivative (3-tetrahydropyranyl ether of 17-beta-estradiol)].
    Plancher G
    Minerva Ginecol; 1971 Sep; 23(17):671-8. PubMed ID: 5131894
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sequence therapy with estradiol valerate-norgestrel at menopause. A double-blind investigation].
    Davidsen PC; Secher NJ; Pedersen GT; Christensen NC
    Ugeskr Laeger; 1974 Aug; 136(32):1805-8. PubMed ID: 4605940
    [No Abstract]   [Full Text] [Related]  

  • 4. [Substitution therapy with steroid hormones in gynecology].
    Lauritzen C
    Dtsch Med J; 1970 Jul; 21(14):925-8 passim. PubMed ID: 5508353
    [No Abstract]   [Full Text] [Related]  

  • 5. [On modern estrogen therapy].
    Resen Clin Cient; 1968; 37(1):21-5. PubMed ID: 4320014
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erroneous treatment with sex hormones in gynecology].
    Kaiser R
    Ther Ggw; 1971 Jan; 110(1):16-30. PubMed ID: 5545645
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
    Signorelli I; Emanueli A
    Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormonal therapy in the climacteric].
    Groot-Wassink
    Z Arztl Fortbild (Jena); 1971 Jan; 65(2):68-73. PubMed ID: 5560240
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nucleosides in certain clinical manifestations in the climacteric age].
    Cazzola D
    Minerva Ginecol; 1967 Aug; 19(15):777-80. PubMed ID: 5612821
    [No Abstract]   [Full Text] [Related]  

  • 10. [The practical physician and his attitude towards the problem of hormone therapy in gynecology].
    Jäger G
    Z Arztl Fortbild (Jena); 1967 Dec; 61(23):1193-8. PubMed ID: 5627209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacological aspects of a new hormone derivative (3-tetrahydropyranyl ether of 17-beta-estradiol)].
    Andreoli C; Lenzi G
    Minerva Ginecol; 1971 Sep; 23(18):711-24. PubMed ID: 5131179
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of estrogens used in the treatment of menopause].
    Basdevant A; Panotopoulos G
    Rev Prat; 1993 Dec; 43(20):2638-43. PubMed ID: 8146564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern hormone therapy in gynecology].
    Husslein H
    Hippokrates; 1967 Jul; 38(13):506-13. PubMed ID: 5611579
    [No Abstract]   [Full Text] [Related]  

  • 14. [The management of climacteric disorders using estradiol valerate (Progynova)].
    Dapunt O
    Med Klin; 1967 Sep; 62(35):1356-61 passim. PubMed ID: 5593020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with sequential therapy].
    Minucci D; Genazzani AR
    Riv Ostet Ginecol; 1967 May; 22(5):316-46. PubMed ID: 5629140
    [No Abstract]   [Full Text] [Related]  

  • 16. [Estriol therapy of the menopause and in the post-menopausal period].
    Proost J; Demol R; Barbier F; Callaerts J; Huyghebaert G; Hooghe R
    Bull Soc R Belge Gynecol Obstet; 1969; 39(1):65-83. PubMed ID: 5791879
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a new combination: dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17 isobutyrate in gynecology].
    Cittadini E; Catalano G
    Riv Ostet Ginecol Prat Med Perinat; 1973-1974; 54(10):506-12. PubMed ID: 4620236
    [No Abstract]   [Full Text] [Related]  

  • 18. [1st research on the treatment of climacteric with a new drug (controlled clinical study)].
    Cazzola D; Confalonieri A; Lucchese V
    Minerva Ginecol; 1974 Mar; 24(5):250-64. PubMed ID: 4603971
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ovarian inhibition treatment in aluteal or dysluteal states with hyperandrogenism].
    Laham E
    Rev Med Moyen Orient; 1967; 24(4):379-82. PubMed ID: 5269293
    [No Abstract]   [Full Text] [Related]  

  • 20. [Our experience with a sequential estro-progestinic agent. Its use in disorders of the menstrual cycle and in the dysautonomic syndrome of the premenopausal period].
    Accinelli G; Cortellardo G; Santoni G; Sbernini R
    Minerva Ginecol; 1976 Feb; 28(2):175-81. PubMed ID: 1256718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.